<p>Section I- Overview of Pharmaceutical Medicine <br>1. The Specialty of Pharmaceutical Medicine</p> <p>Section II- Drug Discovery and Development <br>2. Drug Discovery and Development: An overview<br>3. Pharmaceutical Development<br>4. Preclinical Drug Development<br>5. Target Product Profile and Clinical Development Plan<br>6. Clinical Pharmacokinetics and Drug Interactions<br>7. Pharmacogenomics: An Evolution Towards Clinical Practice<br>8. Clinical Research Quality Assurance and Audits</p> <p>Section III- Pharmaceutical Law and Ethics <br>9. Pharmaceutical Medicine and Law<br>10. Pharmaceutical Regulations in the United States<br>11. Pharmaceutical Regulations in European Union<br>12. Pharmaceutical Regulations in India<br>13. Pharmaceutical Regulations for Complementary Medicine<br>14. Ethical Considerations in Clinical Research</p> <p>Section IV- Pharmaceutical Industry and Intellectual Property Rights <br>15. Patent<br>16. Copyright<br>17. Trademark<br>18. Trade Secret<br>19. Data Exclusivity</p> <p>Section V- Generics, Supergenerics, Biologics, biosimilars and bio-betters <br>20. Generic Drug and Bioequivalence Studies<br>21. Vaccines<br>22. Biosimilars<br>23. Re-innovation in Pharmaceutical Industry: Supergenerics and Biobetters</p> <p>Section VI- Medical Services <br>24. Phase IV Studies and Lifecycle Management<br>25. Medical Affairs</p> <p>Section VII- Pharmacovigilance <br>26. Pharmacovigilance and Drug Safety<br>27. Clinical and Post Approval Safety Data Management<br>28. Individual Case Safety Reports<br>29. Development and Periodic Safety Reports<br>30. Risk Management in Pharmacovigilance<br>31. Recent Developments in Pharmacovigilance at UMC</p> <p>Section VIII- Drug utilization and Pharmacoeconomics <br>32. Assessing Medicine Use and Tools for Monitoring Medicine Use<br>33. Pharmacoeconomics and Healthcare</p>
